ArticleFrontiers in oncology2025
Human papillomavirus-associated anal cancer, vulvar verrucous cancer, and cervical cancer in a post-renal transplant patient-a case report.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human papillomavirus (HPV) can cause tumors at specific anatomical sites in human body. Herein, we report the case of a 73-year-old female patient with a rare presentation of three distinct HPV-associated squamous cell carcinomas (anal, vulvar, and cervical), who had undergone kidney transplantation due to renal failure and was administered long-term cyclosporine, mycophenolate mofetil, and prednisone acetate for 20 years. Evidence of HPV16/59 infection was detected in Evidence of HPV16/59 infection was detected in formalin-fixed paraffin-embedded (FFPE) tissue samples obtained from the patient's vulvar tumor and anal tumor via PCR-based assays, as well as from exfoliated cells of the cervix. This case confirms the potential of HPV to drive carcinogenesis across multiple ano-genital sites within the same patient. Immunosuppression in transplant patients significantly increases the risk of human papillomavirus (HPV)- associated malignancies; however, the synchronous or metachronous development of triple anogenital cancers in a single individual is exceptionally uncommon. This case highlights the aggressive potential of HPV oncogenesis in immunocompromised hosts and underscores the need for rigorous cancer surveillance in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.